Patients' understanding of the regulation of dietary supplements

被引:14
|
作者
Ashar, Bimal H. [1 ]
Miller, Redonda G. [1 ]
Pichard, Carmen P. [2 ]
Levine, Rachel [3 ]
Wright, Scott M. [3 ]
机构
[1] Johns Hopkins Univ, Div Gen Internal Med, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Dept Orthoped Surg, Baltimore, MD 21287 USA
[3] Johns Hopkins Bayview Med Ctr, Div Gen Internal Med, Baltimore, MD 21224 USA
关键词
dietary supplements; dietary supplement health and education act; herbal; food and drug administration; federal trade commission;
D O I
10.1007/s10900-007-9063-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The Dietary Supplement Health and Education Act (DSHEA) permits manufacturers to sell products without providing pre-market evidence of safety or efficacy. One fundamental reason for the passage of the DSHEA was to empower consumers to make their own choices, free from governmental restriction. Yet, little is known about the public's understanding of the supplement regulatory process. We undertook a study to assess patients' knowledge regarding governmental oversight of product marketing and advertising. A survey of 300 adult patients from the Baltimore Metropolitan area was administered after showing participants an advertisement for a dietary supplement. Patients were asked questions regarding their understanding of federal regulation of the advertised product. A total of 52% of respondents were unaware that the dietary supplement had not been approved by the government while 63% were unaware that the advertisement for that supplement had not been pre-approved. Factors associated with a lack of understanding of the product approval process included lower education level (OR 2.52; 95% CI 1.52-4.19) and non-Caucasian race (OR 1.99; 95% CI 1.17-3.36). Lower education level was also associated with confusion regarding the advertisement approval process (OR 2.60; 95% CI 1.48-4.57). Based on these results, patients seem unclear about the government's role in the regulation of dietary supplements. Educational efforts should be geared towards clarifying these issues.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 50 条
  • [41] Dietary Supplements Pose Real Dangers to Patients
    White, C. Michael
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (08) : 815 - 819
  • [42] Dietary supplements for joint use and patients at risk
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2019, 58 (588): : 12 - 12
  • [43] Interactions between dietary supplements in hospitalized patients
    Ilana Levy
    Samuel Attias
    Eran Ben Arye
    Lee Goldstein
    Elad Schiff
    Internal and Emergency Medicine, 2016, 11 : 917 - 927
  • [44] Treatment options and dietary supplements for patients with phenylketonuria
    Rocha, Julio Cesar
    MacDonald, Anita
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (11): : 667 - 681
  • [45] Advising patients who use dietary supplements
    Ashar, Bimal H.
    Rowland-Seymour, Anastasia
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (02): : 91 - 97
  • [46] Use of Dietary Supplements by Patients Taking Digoxin
    Ting, Lillian S. L.
    Shalansky, Stephen J.
    Neall, Erin
    Ensom, Mary H. H.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2008, 61 (01): : 30 - 40
  • [47] Use of dietary supplements among patients with alopecia
    Burns, Laura
    de Souza, Brianna
    Hagigeorges, Dina
    Flynn, Elizabeth
    Prasad, Sonya
    Senna, Maryanne Makredes
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB75 - AB75
  • [48] Interactions between dietary supplements in hospitalized patients
    Maurizio Muscaritoli
    Internal and Emergency Medicine, 2016, 11 : 903 - 904
  • [49] Are dietary supplements safe in heart transplant patients?
    Kumar, N
    Kobashigawa, JA
    Chuang, JM
    Hamilton, M
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 67A - 67A
  • [50] Understanding the Properties of Common Dietary Supplements: Clinical Implications for Healthcare Practitioners
    Zelig, Rena
    Radler, Diane Rigassio
    NUTRITION IN CLINICAL PRACTICE, 2012, 27 (06) : 767 - 776